ta 0910 has been researched along with oxidopamine in 3 studies
Studies (ta 0910) | Trials (ta 0910) | Recent Studies (post-2010) (ta 0910) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
---|---|---|---|---|---|
64 | 2 | 14 | 8,630 | 6 | 2,407 |
Protein | Taxonomy | ta 0910 (IC50) | oxidopamine (IC50) |
---|---|---|---|
Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishida, R; Kinoshita, K; Nakagawa, H; Yamamura, M | 1 |
Honda, M; Ono, H; Ono, K; Takasu, K; Tanabe, M; Tokuda, Y | 1 |
Eto, K; Ishibashi, H; Kim, SK; Nabekura, J | 1 |
3 other study(ies) available for ta 0910 and oxidopamine
Article | Year |
---|---|
Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (II): Involvement of the DA system in the locomotor stimulating action of TA-0910.
Topics: Animals; Catheterization; Corpus Striatum; Dopamine; Hydroxydopamines; Male; Microinjections; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Rotation; Substantia Nigra; Thyrotropin-Releasing Hormone | 1991 |
The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems.
Topics: Adrenergic alpha-Antagonists; Analgesics; Animals; Biogenic Monoamines; Dose-Response Relationship, Drug; Fenclonine; Hot Temperature; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Ketanserin; Male; Mice; Mice, Inbred ICR; Naloxone; Narcotic Antagonists; Neural Pathways; Norepinephrine; Oxidopamine; Pain Measurement; Physical Stimulation; Reaction Time; Serotonin; Serotonin Agents; Sympatholytics; Thyrotropin; Thyrotropin-Releasing Hormone; Yohimbine | 2007 |
Taltirelin, a thyrotropin-releasing hormone analog, alleviates mechanical allodynia through activation of descending monoaminergic neurons in persistent inflammatory pain.
Topics: Adrenergic Agents; Animals; Biogenic Monoamines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Fenclonine; Freund's Adjuvant; Gene Expression Regulation; Hyperalgesia; Inflammation; Mice; Nootropic Agents; Oxidopamine; Pain; Pain Measurement; Pain Threshold; Piperazines; Pyridines; Serotonin Antagonists; Thyrotropin-Releasing Hormone | 2011 |